There's a slew of things pros on the Street believe that just don't seem to make a lot of sense.» Read More
The Fed is expected to end its quantitative easing program—the much-anticipated action that's been at the very heart of the market's fears.
If you’re saving for retirement and panicked by the volatility in the market, at least one pro questions your Street smarts.
Pro investor Ralph Acampora sees no reason for the rally to end. “October was its obnoxious self,” he said. He likes November better.
In the wake of a deadly attack this week in Canada, traders have been forced to reconcile the potential of increased terrorism. What you must know?
Oil companies have yet to cut production and capital expenditures amid low oil prices. But if oil drops furthers, that could change.
His company just suffered a setback, but this CEO is still tops with the Harvard Business Review.
Investors were closely monitoring developments in the attempts to contain Ebola after a new case was diagnosed in New York City.
Crude oil continues to flirt with the key $80 per barrel level, signaling another possible sharp leg down in price in the coming weeks.
But long time stock bull Jeremy Siegel tells CNBC it looks like the stock market hit its recent bottom last week.
Some of the names on the move ahead of the open.
One survey found that gender diversity on corporate boards is correlated to steady, positive performance.
U.S. drugmaker Pfizer's new $11 billion share repurchase plan is deflating expectations that it will make a new bid for AstraZeneca.
Amazon's huge earnings miss may be the last straw for investors.
Despite the swings in the market, favoring fixed-income or bond funds over equity or stocks in a retirement account could be a mistake. Here's why.
Stocks head into Friday on track for the best weekly performance in 22 months, yet new Ebola fears and other geopolitical headlines could be wild cards.
Check out which companies are making headlines after the bell Thursday: Amazon, Microsoft, Pfizer & more.
Good earnings and improving economic data are causing money to pile into the U.S. stock market.
Given the massive swings in the market, it would stand to reason that worry in the market should go from bad to worse. It's going the other way.
After salivating at the Alibaba IPO, hedge fund managers lucky enough to buy in early are indeed getting a nice kick to their returns.
Financial firms are shelling out big cash for the mid-term Senate elections, but their favorite candidate is an unlikely one.
Get the best of CNBC in your inbox